Search

everythinglearnresearchcommunity

for

Search:↓

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Imuvert can prevent some chemotherapy-induced hair loss.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

Some breast cancer patients treated with high-dose docetaxel may experience permanent hair loss.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Immunotherapy can help treat severe alopecia areata.

CTP-543 is generally safe for treating alopecia areata.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Oral tofacitinib effectively regrows hair in children with alopecia areata without major side effects.

The treatment combination is effective and generally safe for lung cancer.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

Cold Atmospheric Plasma shows promise in treating aggressive breast cancer by targeting cancer cells while sparing normal tissue.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Apremilast helps regrow hair in hard-to-treat alopecia areata.

Bortezomib chemotherapy can cause temporary skin rashes.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.